文献速递类风湿关节炎系统性红斑狼疮血管炎

二聚化是自身反应性IgA抗体应答的关键特征

Dimerization as a key feature of autoreactive IgA antibody responses.
PubMed 文献 · Ann Rheum Dis · 2025-11-29

该研究通过尺寸排阻色谱和ELISA分析风湿病患者、SARS-CoV-2疫苗接种者及健康对照血浆中IgA的分子大小,发现自身抗体中二聚体IgA比例在RA、AAV和SLE中升高(约60%-80% vs 总IgA约20%,SLE总IgA约60%),SSc中未见升高;SARS-CoV-2肌内接种后抗刺突IgA二聚体比例短期升高。结论提示二聚体自身反应性IgA与新生抗原特异性免疫激活相关,黏膜触发并非必需。

要点

  • RA、AAV和SLE中自身抗体二聚体IgA比例约60%-80%,高于总IgA约20%。
  • SSc中未见二聚体IgA比例升高。
  • SARS-CoV-2肌内接种后抗刺突IgA二聚体比例短期升高,与既往黏膜暴露无关。

核心结论

  • 二聚体(自身反应性)IgA应答与新生抗原特异性免疫激活相关,产生暂时向二聚体IgA偏移。
  • 黏膜触发并非总是参与这些IgA免疫应答。
  • 二聚体IgA可能作为自身免疫中免疫疾病活动的标志物。

研究设计与样本

  • 采用尺寸排阻色谱(SEC)分析风湿病患者(RA、SSc、AAV、SLE)、SARS-CoV-2疫苗接种健康个体及健康对照的血浆。
  • 对SEC组分进行ELISA以确定IgA大小,并用蛋白质印迹和串联质谱确认结果。

主要发现

  • 自身抗体中二聚体IgA比例较总IgA升高,在RA、AAV和SLE中最明显(二聚体自身反应性IgA约60%-80% vs 总IgA约20%,SLE总IgA约60%),但SSc中未见。
  • SARS-CoV-2肌内接种后短期内抗刺突IgA二聚体比例升高,与既往黏膜暴露无关。

局限性

  • 原文未述局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: The presence of immunoglobulin A (IgA) autoantibodies has been described in many autoimmune diseases, and some of its characteristics, such as IgA dimerization, are considered a sign of a mucosal origin. However, limited information is available about the (patho)physiological conditions leading to the development of monomeric vs dimeric (autoreactive) IgA in humans. Therefore, we investigated IgA dimerization in rheumatic autoimmune diseases with a possible mucosal origin, as well as after vaccination. METHODS: Plasma of patients with rheumatic disease (rheumatoid arthritis [RA], systemic sclerosis [SSc], anti-neutrophil cytoplasmic antibody associated vasculitis [AAV], systemic lupus erythematosus [SLE]), SARS-CoV-2 vaccinated healthy individuals, and healthy controls was used for size exclusion chromatography (SEC). Enzyme-linked immunosorbent assays were performed on SEC fractions to determine the size of IgA. Results were confirmed using western blot and tandem mass spectrometry. RESULTS: The proportion of dimeric IgA was increased for autoantibodies compared to total IgA. This was most evident in RA, AAV, and SLE (dimeric autoreactive IgA ≈ 60%-80% vs total IgA ≈ 20%, SLE ≈ 60% total IgA), but not in SSc. Intramuscular vaccination against SARS-CoV-2 also led to an increased proportion of dimeric anti-spike IgA shortly after vaccination, irrespective of previous mucosal exposure. CONCLUSIONS: These findings indicate that dimeric (autoreactive) IgA responses are associated with newly emerging antigen-specific immune activation, where production temporarily shifts to dimeric IgA. Mucosal triggering is not necessarily always involved in these IgA immune responses. These findings provide key insights into the circumstances for IgA dimerization and suggest that dimeric IgA could serve as a marker for immunological disease activity in autoimmunity.

来源:Ann Rheum Dis,查看原文。版权归原作者所有。

引用

  1. van Mourik AG, Keijser JBD, van Delft MAM, et al. Dimerization as a key feature of autoreactive IgA antibody responses. Ann Rheum Dis. 2025. PMID: 41318346. doi:10.1016/j.ard.2025.11.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。